Shingles at injection site; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced shingles (Verbatim: Shingles at injection site). The outcome of the shingles was not resolved. It was unknown if the reporter considered the shingles to be related to Shingrix. It was unknown if the company considered the shingles to be related to Shingrix. Additional Information: GSK Receipt Date: 26-JAN-2025 The patient self-reported this case for himself/herself. The patient had first shot and developed shingles at the injection site. The patient reported that it had been almost 4 months and he/she was still in a breakout stage. The patient asked should he/she get the 2nd shot.